Interestingly, binding to the promoter region was higher in NFYAv2OE cells than in wild-type cells, supporting that NFYAv2 predominantly regulates PCK1 transcription, thereby contributing to its anti-tumor effects. The gene discussed is PCK1; the disease is neoplasm.